Stayble Therapeutics AB
559024-8372ActiveDeveloping an injection treatment for pain caused by disc herniation.
Oversigt
- 5–9
- Medarbejdere
- 300–399t SEK
- Omsætning
- 2015
- Grundlagt
Nøglebeslutningstagere
Andreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
Chief Financial Officer
Gunnar Fernström
Board member
+4 flere kontakter i Funnelfeedr
Beskrivelse
Stayble Therapeutics is a clinical pharmaceutical company focused on developing innovative treatments for debilitating leg pain caused by Lumbar Disc Herniation (LDH). Their core product candidate, STA363, is a patented, disease-modifying treatment administered via a single injection. This therapy a...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559024837201
Beslutningstagere
8 kontakter i FunnelfeedrAndreas Gerward
CEO
Anders Lehmann
Chief Scientific Officer
Erik Kullgren
Chief Financial Officer
Gunnar Fernström
Board member
Ulf Björklund
Chairman of the Board
Jane Buus Laursen
Board member
Gudrun Anstrén
Board member
Erik Kinnman
Board member
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrSynartro AB
1–4 medarbejdereDeveloping sustained local injection treatments for osteoarthritis pain relief.
Paayia Thaimassage
Professional traditional Thai massage services offered in Örebro.
Pharmnovo Aktiebolag
1–4 medarbejdereDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Intercedo AB
0 medarbejdereDeveloping medical products focused on improving quality of life.
PILA PHARMA AB
1–4 medarbejdereClinical stage biotech developing an oral obesity and diabetes treatment.
Udforsk mere
Spørgsmål om Stayble Therapeutics AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo